Latest filing published 01 Oct 2019 for CorMedix Inc., €6,312.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -3.5%Entry US$6.23 · Close at T+365 US$6.01
- -40.5%Entry US$8.29 · Close at T+365 US$4.93
- -70.1%Entry US$10.57 · Close at T+365 US$3.16
- -8.5%Entry US$6.70 · Close at T+365 US$6.13
- +122.8%Entry US$2.85 · Close at T+365 US$6.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert W. Cook: trading record in brief
Robert W. Cook is a declared insider at 3 companies; the most frequent names are CorMedix Inc., Immune Pharmaceuticals Inc and STRATA Skin Sciences, Inc. Between 29 August 2007 and 30 September 2019, the trades on record add up to 14 filings.
No open-market sale appears; the market trades are 12 purchases worth €119k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 option exercises. Since January 2019: 4 purchases and no sales on the market.
The median purchase comes to €7,360. 6 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 7 purchases show a median change of -11.4%, with the price up in 43% of them. These figures describe past trades and do not predict future prices.
On 1 October 2019 came the latest disclosure, an open-market purchase for €6,312 in CorMedix Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert W. Cook
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$6.8815.7% of flowCommon StockSEC:0001213900-19-019412:0Canonical exit: 29 Dec 2019 (T+90)
- 1,000 shares@ US$8.1818.3% of flowCommon StockSEC:0001213900-19-016280:0Canonical exit: 14 Nov 2019 (T+90)
- 100 shares@ US$9.352.1% of flowCommon StockSEC:0001654954-19-003866:0Canonical exit: 27 Jun 2019 (T+90)
- 25,000 shares@ US$1.1764.0% of flowCommon StockSEC:0001654954-18-013260:0Canonical exit: 25 Feb 2019 (T+90)
- 52,083 shares@ US$0.4825.2% of flowCommon StockSEC:0001654954-17-011650:0Canonical exit: 12 Mar 2018 (T+90)
- 50,000 shares@ US$0.49927.0% of flowCommon StockSEC:0001354488-17-000513:0Canonical exit: 13 Aug 2017 (T+90)
- 10,000 shares@ US$1.23Common StockSEC:0001209191-15-000222:0Canonical exit: 31 Mar 2015 (T+90)
- 100,000 shares0Common StockSEC:0001208261-12-000012:0
- 350,000 shares0Common StockSEC:0001208261-12-000012:1
- 5,000 shares@ US$1.35Common Stock, par value $0.0001SEC:0000909518-07-001068:0Canonical exit: 12 Mar 2008 (T+90)
- 8,197 shares@ US$1.66Common Stock, par value $0.0001SEC:0000909518-07-000795:0Canonical exit: 27 Nov 2007 (T+90)
- 900 shares@ US$1.68Common Stock, par value $0.0001SEC:0000909518-07-000795:1Canonical exit: 28 Nov 2007 (T+90)
- 903 shares@ US$1.70Common Stock, par value $0.0001SEC:0000909518-07-000795:2Canonical exit: 28 Nov 2007 (T+90)
13 of 13 declarations
